(9974) Oncology Pathways: payments to doctors
Payments that named (9974) Oncology Pathways as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $497K
- Providers
- 0
- Transactions
- 8
- Average per transaction
- $62,124
The per-transaction average — $62,124 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Philips North America LLC | $271,390 | 54.6% |
| Philips Electronics North America Corporation | $225,600 | 45.4% |